131 related articles for article (PubMed ID: 23178664)
1. Treatment of experimental murine colitis with CD40 antisense oligonucleotides delivered in amphoteric liposomes.
Arranz A; Reinsch C; Papadakis KA; Dieckmann A; Rauchhaus U; Androulidaki A; Zacharioudaki V; Margioris AN; Tsatsanis C; Panzner S
J Control Release; 2013 Feb; 165(3):163-72. PubMed ID: 23178664
[TBL] [Abstract][Full Text] [Related]
2. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
[TBL] [Abstract][Full Text] [Related]
3. CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis.
Gao D; Wagner AH; Fankhaenel S; Stojanovic T; Schweyer S; Panzner S; Hecker M
Gut; 2005 Jan; 54(1):70-7. PubMed ID: 15591506
[TBL] [Abstract][Full Text] [Related]
4. Targeting delivery of anti-TNFalpha oligonucleotide into activated colonic macrophages protects against experimental colitis.
Zuo L; Huang Z; Dong L; Xu L; Zhu Y; Zeng K; Zhang C; Chen J; Zhang J
Gut; 2010 Apr; 59(4):470-9. PubMed ID: 19951904
[TBL] [Abstract][Full Text] [Related]
5. Blockade of STAT3 by antisense oligonucleotide in TNBS-induced murine colitis.
Bai A; Hu P; Chen J; Song X; Chen W; Peng W; Zeng Z; Gao X
Int J Colorectal Dis; 2007 Jun; 22(6):625-35. PubMed ID: 17089128
[TBL] [Abstract][Full Text] [Related]
6. Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions.
Liu Z; Geboes K; Colpaert S; Overbergh L; Mathieu C; Heremans H; de Boer M; Boon L; D'Haens G; Rutgeerts P; Ceuppens JL
J Immunol; 2000 Jun; 164(11):6005-14. PubMed ID: 10820284
[TBL] [Abstract][Full Text] [Related]
7. Antisense therapy of MAdCAM-1 for trinitrobenzenesulfonic acid-induced murine colitis.
Goto A; Arimura Y; Shinomura Y; Imai K; Hinoda Y
Inflamm Bowel Dis; 2006 Aug; 12(8):758-65. PubMed ID: 16917232
[TBL] [Abstract][Full Text] [Related]
8. Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease.
Ichikawa N; Yamashita K; Funakoshi T; Ichihara S; Fukai M; Ogura M; Kobayashi N; Zaitsu M; Yoshida T; Shibasaki S; Koshizuka Y; Tsunetoshi Y; Sato M; Einama T; Ozaki M; Umezawa K; Suzuki T; Todo S
Inflamm Res; 2016 Mar; 65(3):245-60. PubMed ID: 26683259
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
[TBL] [Abstract][Full Text] [Related]
10. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses.
Kelsall BL; Stüber E; Neurath M; Strober W
Ann N Y Acad Sci; 1996 Oct; 795():116-26. PubMed ID: 8958922
[TBL] [Abstract][Full Text] [Related]
12. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
[TBL] [Abstract][Full Text] [Related]
13. Cinnamon extract suppresses experimental colitis through modulation of antigen-presenting cells.
Kwon HK; Hwang JS; Lee CG; So JS; Sahoo A; Im CR; Jeon WK; Ko BS; Lee SH; Park ZY; Im SH
World J Gastroenterol; 2011 Feb; 17(8):976-86. PubMed ID: 21451725
[TBL] [Abstract][Full Text] [Related]
14. Topical delivery of interleukin-13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis.
Kim ST; Lee KM; Park HJ; Jin SE; Ahn WS; Kim CK
J Gene Med; 2009 Jan; 11(1):26-37. PubMed ID: 19006098
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant serine protease from adult stage of Trichinella spiralis on TNBS-induced experimental colitis in mice.
Pang J; Ding J; Zhang L; Zhang Y; Yang Y; Bai X; Liu X; Jin X; Guo H; Yang Y; Liu M
Int Immunopharmacol; 2020 Sep; 86():106699. PubMed ID: 32570037
[TBL] [Abstract][Full Text] [Related]
16. The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in mice.
Pfister K; Wittig BM; Jüngling B; Ecker KW; Barth S; Huhn M; Sasse S; Engert A; Mueller-Molaian I; Diehl V; Zeitz M; Stallmach A
Int J Colorectal Dis; 2002 Mar; 17(2):77-84. PubMed ID: 12014425
[TBL] [Abstract][Full Text] [Related]
17. T-cell regulation of neutrophil infiltrate at the early stages of a murine colitis model.
van Lierop PP; de Haar C; Lindenbergh-Kortleve DJ; Simons-Oosterhuis Y; van Rijt LS; Lambrecht BN; Escher JC; Samsom JN; Nieuwenhuis EE
Inflamm Bowel Dis; 2010 Mar; 16(3):442-51. PubMed ID: 19714763
[TBL] [Abstract][Full Text] [Related]
18. The intestinal anti-inflammatory effects of the novel agent UR-1505 in the TNBS model of rat colitis are mediated by T-lymphocyte inhibition.
Bailón E; Camuesco D; Nieto A; Concha A; Fernández de Arriba A; Román J; Ramis I; Merlos M; Zarzuelo A; Gálvez J; Comalada M
Biochem Pharmacol; 2007 Nov; 74(10):1496-506. PubMed ID: 17720145
[TBL] [Abstract][Full Text] [Related]
19. Crotoxin from Crotalus durissus terrificus is able to down-modulate the acute intestinal inflammation in mice.
Almeida Cde S; Andrade-Oliveira V; Câmara NO; Jacysyn JF; Faquim-Mauro EL
PLoS One; 2015; 10(4):e0121427. PubMed ID: 25853847
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis.
Boirivant M; Pallone F; Di Giacinto C; Fina D; Monteleone I; Marinaro M; Caruso R; Colantoni A; Palmieri G; Sanchez M; Strober W; MacDonald TT; Monteleone G
Gastroenterology; 2006 Dec; 131(6):1786-98. PubMed ID: 17087939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
